Add BrightSurf on Google Email

Long COVID and recovery among US adults

A recent study found that nearly 6 in 10 long COVID patients have recovered, but many adults over 35 continue to experience lasting symptoms. The study's authors suggest greater investment in understanding biological mechanisms may provide insights into pathways of persistence and potential targets for intervention.

SourceJAMA Network·JournalJAMA Network Open·DateMar 2, 2026

Insights to innovation: Insilico Medicine AI-driven practice published on Springer Nature in latest AI for Drug Discovery Volume

The article highlights Insilico Medicine's exclusive contributions to two chapters in the latest AI for Drug Discovery Volume, showcasing its expertise in real-life application of AI in early drug target-related tasks. The company's roadmap to 2030 using Quantum Machine Learning (QML) algorithms is also presented, with successful case ...

Thirst and hunger neurons

New research identifies specific populations of neurons in the amygdala that play a key role in regulating nutritional needs and turning them into action. The study reveals distinct groups of neurons responding to thirst and hunger, guided by molecular cues.

SourceMax-Planck-Gesellschaft·JournalNature Communications·DateApr 3, 2025

CNIC scientists discover a type of immune cell that produces defensive "shields" in the skin

Researchers have identified a type of immune cell that produces extracellular matrix, strengthening the skin's defensive function and maintaining its integrity. This discovery may lead to new strategies for treating skin diseases, inflammation, diabetes, and age-related conditions.

Chinese Medical Journal article reveals the anticancer potential of poly ADP-ribose polymerase inhibitors

PARP inhibitors have been found to be effective in treating cancers with BRCA1/2 mutations by blocking DNA repair pathways. The combination of PARPis with chemotherapeutic drugs can also improve treatment efficacy, increasing DNA damage and blocking repair processes.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateMar 4, 2025

Air pollution clouds the mind and makes everyday tasks challenging

Research reveals that even short-term exposure to high levels of particulate matter air pollution impairs cognitive functions such as selective attention and emotion recognition. This study highlights the urgent need for stricter air quality regulations and public health measures to combat the harmful effects of pollution on brain health.

SourceUniversity of Birmingham·JournalNature Communications·TypeData/statistical analysis·DateFeb 6, 2025

New insights into the immunomodulatory properties of russula polysaccharides

Researchers explore structural and functional characteristics of Russula vinosa Lindblad polysaccharides, finding potential applications in pharmaceuticals and functional foods. The study reveals that structural differences between polysaccharides influence immunomodulatory activities.

SourceJournal of Bioresources and Bioproducts·JournalJournal of Bioresources and Bioproducts·TypeExperimental study·DateJan 29, 2025

POSTECH team pioneers new cancer therapy strategy: targeting GLUT3 in regulatory T cells to supercharge anti-tumor immunity

Researchers at POSTECH have identified GLUT3 as essential for the suppressive function of regulatory T cells in tumor microenvironments, which can be targeted for cancer immunotherapy. The team's findings highlight the critical role of GLUT3 in regulating protein modifications that sustain immune suppression within tumors.

SourcePohang University of Science & Technology (POSTECH)·JournalCellular and Molecular Immunology·DateNov 12, 2024

New option for treating prostate cancer

A new strategy for treating prostate cancer has been developed by blocking the GP130 signalling pathway, contrary to current medical understanding. The study found that activating GP130 in prostate cells reduces tumour growth and stimulates the immune system to fight cancer cells.

SourceMedical University of Vienna·JournalMolecular Cancer·DateNov 8, 2024

PARP1 selective inhibitor yields potent and durable antitumor activity in patient-derived preclinical models

Researchers found saruparib to be superior and durable in treating PDX models with BRCA1/2 alterations, outperforming olaparib in terms of complete response rate and progression-free survival. The study's results suggest the promise of PARP1 selective inhibitors as a new therapeutic option for patients with advanced solid tumors.

SourceVall d'Hebron Institute of Oncology·JournalGenome Medicine·DateSep 3, 2024

Cover paper: Senescent characteristics of human corneal endothelial cells upon UV-A exposure

Researchers investigate senescence phenotypes of human corneal endothelial cells upon treatment with ultraviolet (UV)-A. Cells exhibit enlarged morphology, increased β-galactosidase activity and decreased proliferation. UV-A-induced senescent cells show similar gene expression profiles to ionizing radiation (IR)-induced cells.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateApr 30, 2024

Psychiatric symptoms, treatment uptake, and barriers to mental health care among US adults with post–COVID-19 condition

A nationally representative study of 25,000 participants found that US adults with post-COVID-19 condition are more likely to experience depression and anxiety symptoms than the general population. Individuals with these symptoms reported higher rates of cost-related barriers to accessing mental health treatment.

SourceJAMA Network·JournalJAMA Network Open·DateApr 25, 2024

Progression of ALS linked to a membrane and an enzyme: mitochondria-endoplasmic reticulum disruption and loss of TBK1 activity

Researchers at Nagoya University have discovered a relationship between ALS progression and the disruption of mitochondria-associated membranes (MAM) and TBK1 activity. Decreased activation of TBK1 is linked to motor neuron death in ALS patients and mice with disrupted MAM.

SourceNagoya University·JournalProceedings of the National Academy of Sciences·DateJan 17, 2024

Challenging the traditional views on how the brain processes movement and sensation

A study by Fujita Health University researchers unveiled novel insights into the brain's processing of movement and sensation. The findings suggest that signals from motor cortices do not primarily modulate sensory responses in primary sensory cortices, but rather pathways from secondary somatosensory cortex (S2) and sensory thalamus (...

SourceFujita Health University·JournalJNeurosci·TypeExperimental study·DateJan 11, 2024

Spanish scientists identify the molecular mechanisms controlling the genes involved in proper formation of the heart valves

Researchers at the Centro Nacional de Investigaciones Cardiovasculares discovered the molecular mechanisms behind proper heart valve formation and prevention of calcification. They found that Notch signaling pathway disruption causes both valve defects and calcification.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalCirculation Research·TypeExperimental study·DateDec 11, 2023

Suppression of cancer stemness and drug resistance via BRAF/EGFR/MEK inhibition in colorectal cancer cells

Researchers discovered that inhibiting the BRAF/EGFR/MEK pathway significantly reduced cancer stemness and drug resistance in primary colorectal cancer cells. The study also identified a triple combination treatment against BRAF, EGFR, and MEK as a promising approach to block these activities and develop effective treatments.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateOct 11, 2023

Human senescent fibroblasts cause lung fibrosis in mice

Researchers found that human senescent fibroblasts trigger progressive lung fibrosis in immunodeficient mice by inducing paracrine senescence and pro-fibrotic activities. The study also suggests that senolytic compounds like navitoclax can ameliorate lung fibrosis induced by senescent human fibroblasts.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJul 31, 2023